IDEAYA director granted 20,000 stock options
IDEAYA Biosciences director Scott W. Morrison received a grant of stock options for 20,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IDEAYA Biosciences director Scott W. Morrison received a grant of stock options for 20,000 shares of Common Stock. The options have an exercise price of $30.57 per share and expire on June 16, 2036. All 20,000 shares vest on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting, if he remains on the Board through that date.
This is a compensation-related award, not an open-market purchase or sale, and leaves him with 20,000 derivative securities reported after the transaction.
Insider Trade Summary
Grant/Award: 20,000 shares
Grant/Award
1 txn
Insider
Morrison Scott W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.
Key Figures
Option grant size: 20,000 options
Exercise price: $30.57 per share
Underlying shares: 20,000 shares
+2 more
5 metrics
Option grant size
20,000 options
Stock Option (right to buy) granted to director Morrison
Exercise price
$30.57 per share
Exercise price for 20,000 stock options
Underlying shares
20,000 shares
Common Stock underlying the option grant
Expiration date
June 16, 2036
Option expiration for the 20,000-share grant
Post-transaction derivative holdings
20,000 derivative securities
Total options held after the reported grant
Key Terms
Stock Option (right to buy), Common Stock, exercise price, Annual Meeting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: "30.5700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual Meeting financial
"immediately prior to the Annual Meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
vesting financial
"shares subject to the option shall vest in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did IDEAYA Biosciences (IDYA) director Scott Morrison report on this Form 4?
Scott Morrison reported a grant of stock options for 20,000 shares of IDEAYA Biosciences Common Stock. The award is compensation-related and not an open-market trade, reflecting additional equity incentives tied to his continued Board service.
What are the key terms of Scott Morrison’s new IDEAYA (IDYA) stock options?
The options cover 20,000 shares of IDEAYA Common Stock at an exercise price of $30.57 per share. They expire on June 16, 2036, giving Morrison a long-dated opportunity to purchase shares at that fixed price.
When do Scott Morrison’s IDEAYA (IDYA) stock options vest?
All 20,000 option shares vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting. Vesting requires Morrison to continue serving on the Board through the applicable vesting date.
Is Scott Morrison’s Form 4 for IDEAYA (IDYA) a stock purchase or sale?
The Form 4 reports an acquisition of derivative securities through a stock option grant, not a market purchase or sale. No open-market buying or selling occurred; it is a compensation grant classified as a grant, award, or other acquisition.
How many IDEAYA (IDYA) derivative securities does Scott Morrison hold after this grant?
After this grant, Morrison is reported as holding 20,000 derivative securities in the form of stock options. These options are directly owned and correspond to 20,000 underlying shares of IDEAYA’s Common Stock, subject to vesting and future exercise decisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates